SickKids Selects GenoLogics for an Integrated Lab and Data Management Solution
News Jan 28, 2009
GenoLogics announced that The Centre for Applied Genomics at The Hospital for Sick Children (SickKids) is deploying its lab and data management solution across multiple facilities of its genome centre.
The GenoLogics solution will be deployed for TCAG’s Microarray Analysis and Gene Expression Facility, DNA Sequencing and Synthesis Facility, Cytogenomics and Genome Resources Facility and Genetic and Statistical Analysis Facility.
“We required a single LIMS that was flexible enough to automate data capture and workflows for each service provided, while still being able to integrate billing, reporting and sample tracking across the entire operation“, said Dr. Steve Scherer, Director of The Centre for Applied Genomics. “The solution from GenoLogics was the only one with proven capabilities to integrate data across the multiple platforms we use, while also meeting our need to effectively and efficiently serve customers around the world.”
Since Geneus is designed for the needs of genomics core facilities, the lab and data management solution can be deployed to provide TCAG with immediate value. Pre-configured integrations to more than 20 of the instruments in use at TCAG means Geneus will improve data quality and workflow management for the entire operation.
TCAG is also deploying GenoLogics’ web collaboration tool, LabLink, and adaptive reporting engine in order to generate and share information with its customers.
“GenoLogics has invested considerable resources in working closely with leading instrument vendors such as Illumina, ABI and Affymetrix to ensure our informatics platform is tightly integrated with multiple instruments,” said Sal Sanci, VP of Product Management for GenoLogics. “Our capability to provide organizations such as TCAG with an end-to-end, lab and data management solution is because we are exclusively focused on serving the unique needs of life sciences research.”
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare DiseasesNews
Researchers at the LSU Computational Systems Biology group have developed a sophisticated and systematic way to identify existing drugs that can be repositioned to treat a rare disease or condition.READ MORE